The company’s shares of confidence were underlined by an upgraded 2026 outlook, with Merck now expecting annual net sales of up to €21.4 billion and EBITDA pre of as much as €6.1 billion
Researchers reported that patients treated with the wearable system were discharged around five days earlier than those receiving standard hospital-based care
This marks the second consecutive year that Juneja has made a personal contribution towards supporting the armed forces
In the new study, scientists at the University of Virginia used gene-editing techniques to modify GLP-1 receptors in mice to make them more humanlike
Study published BY IIT Kanpur researchers could advance drug delivery and biomedical technologies
Around 2,000 runners participated in the awareness run organised during World Retinoblastoma Awareness Week
The Union Minister reviewed DST-supported SATHI-BHU facility
The once-daily oral therapy is the first and only tyrosine kinase 2 (TYK2) inhibitor approved in the European Union for this indication, marking a significant expansion of its immunology portfolio
The facility combines advanced diagnostics, bone marrow transplant evaluation, prenatal awareness, and multidisciplinary support services
The investment will upgrade and expand production capabilities at Lilly Lebanon API and Lilly Lebanon Advanced Therapies
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
